SEC Filings
State Street Holds 5.2% Of Syndax — It Says The Stake Isn't For Control
The institution reported 4,653,172 shares, while Syndax's new finance chief received an option award tied to continued service.
Syndax Pharmaceuticals (SNDX) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
The institution reported 4,653,172 shares, while Syndax's new finance chief received an option award tied to continued service.
Earnings
Management says transplant patients pausing then resuming Revuforj will lift revenue most in 2027, as third-quarter revenue hit $83.3 million.
Earnings
Third-quarter revenue rose 82% to $83.3 million, the net loss narrowed, and Aaron Ondrey replaces retiring CFO Keith Goldan on November 9.
SEC Filings
Royalty financing and new convertible notes outweigh a $551.1 million cash and investments pile on Syndax's balance sheet.